{
    "organizations": [],
    "uuid": "1ec74e4201ffc12e25685c98444de25ac5da8f0f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-titan-pharmaceuticals-q4-loss-per/brief-titan-pharmaceuticals-q4-loss-per-share-0-17-idUSASC09UEQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Titan Pharmaceuticals Q4 Loss Per Share $0.17",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2 (Reuters) - Titan Pharmaceuticals Inc:\n* TITAN PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.17 * AT DEC 31, 2017, TITAN HAD CASH OF ABOUT $7.5 MILLION, WHICH CO BELIEVES IS SUFFICIENT TO FUND PLANNED OPERATIONS INTO Q3 OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-02T19:04:00.000+03:00",
    "crawled": "2018-04-03T16:22:49.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "titan",
        "pharmaceutical",
        "inc",
        "titan",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "dec",
        "titan",
        "cash",
        "million",
        "co",
        "belief",
        "sufficient",
        "fund",
        "planned",
        "operation",
        "q3",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}